ALK Positive Lung Cancer UK is a registered charity established by patients, their families and friends. ALK Positive lung cancer is a rare and relatively unknown form of lung cancer caused by the abnormal rearrangement of the anaplastic lymphoma kinase gene. Founded in 2018, our purposes are to provide support and advocacy and to improve the overall survival and quality of life of ALK positive lung cancer patients across the United Kingdom. We are recognised by the National Institute for Health and Care Excellence (NICE) as an organisation to be consulted on new ALK positive treatments.